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Abstract
Objectives
Calcium-containing crystals participate in the pathogenesis of OA. Sodium thiosulfate
(STS) has been shown to be an effective treatment in calcification disorders such as calci-
phylaxis and vascular calcification. This study investigated the effects and mechanisms of
action of STS in a murine model of OA and in chondrocyte calcification.
Methods
Hydroxyapatite (HA) crystals-stimulated murine chondrocytes and macrophages were
treated with STS. Mineralization and cellular production of IL-6, MCP-1 and reactive oxygen
species (ROS) were assayed. STS's effects on genes involved in calcification, inflammation
and cartilage matrix degradation were studied by RT-PCR. STS was administered in the
menisectomy model of murine OA, and the effect on periarticular calcific deposits and carti-
lage degeneration was investigated by micro-CT-scan and histology.
Results
In vitro, STS prevented in a dose-dependent manner calcium crystal deposition in chondro-
cytes and inhibited Annexin V gene expression. In addition, there was a reduction in crystal-
induced IL-6 and MCP-1 production. STS also had an antioxidant effect, diminished HA-
induced ROS generation and abrogated HA-induced catabolic responses in chondrocytes.
In vivo, administration of STS reduced the histological severity of OA, by limiting the size of
new periarticular calcific deposits and reducing the severity of cartilage damage.
Conclusions
STS reduces the severity of periarticular calcification and cartilage damage in an animal
model of OA via its effects on chondrocyte mineralization and its attenuation of crystal-
induced inflammation as well as catabolic enzymes and ROS generation. Our study sug-
gests that STS may be a disease-modifying drug in crystal-associated OA.
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Introduction
Osteoarthritis (OA) is a joint disease, characterized by degeneration of articular cartilage,
osteophytes formation and synovial lining hyperplasia [1, 2]. OA affects millions of people
worldwide and is the most prevalent cause of disability in the elderly. As such, it represents a
major medical, economic and social challenge for aging societies. Current OA treatment strate-
gies aim at addressing the symptomatic consequences of the disease rather than its underlying
causes and surgical joint replacement still constitutes the final therapeutic option in the man-
agement of OA. Therapeutic alternatives that could affect the progression of the underlying
disease and stop or reverse OA progression would represent a major breakthrough.
A potentially important but still poorly studied feature of OA is its intra-articular calcium-con-
taining crystals deposition. Crystal deposits were identified in half of OA synovial fluids [3] and in
all OA cartilage samples from knee or hip joint replacement surgery [4]. In vitro, calcium-contain-
ing crystals can induce mitogenesis as well as catabolic and inflammatory responses [5–12]. Basic
calcium phosphate (BCP) crystals,—which encompass, hydroxyapatite (HA), carbonated apatite
(CA) and octacalcium phosphate (OCP) crystals—and calcium pyrophosphate dihydrate (CPPD)
are the two most common forms of crystals found in OA joint structures. The importance of BCP
crystals in OA pathogenesis was recently demonstrated through intra-articular injection of BCP
crystals which led to a chronic arthropathy in mice characterized by low grade inflammation and
cartilage degradation [13]. More recently, in menisectomized mice, a validated model of OA, we
observed an accumulation of joint calcific deposits in the form of BCP crystals. In this model, crys-
tal deposition correlated with cartilage degradation and IL-6 expression [14]. Thus, compounds
that interfere with crystal deposition ought to bring therapeutic benefit in the context of OA.
Different agents have been used to prevent calcification or its consequences in OA: phos-
phocitrate was shown to block the deleterious cellular responses stimulated by calcium-con-
taining crystals and to prevent hydroxyapatite crystal formation with promising disease-
modifying effects in both crystal-associated [15] and noncrystal-associated [16] OA models. In
contrast, bisphosphonates, which can induce complete dissolution of arterial calcification sec-
ondary to the mutation in the ectonucleotide pyrophosphatase/phosphodiesterase (PC-1) gene
[17], failed to inhibit the development of experimental OA [18]. In here we assess the therapeu-
tic effect of sodium thiosulfate (STS, Na2S2O3) in the context of OA. STS was initially used to
prevent or treat various conditions, such as cyanide poisoning, carboplatin, cisplatin-induced
nephrotoxicity and renal lithiasis. Later it prove effective in calcium-associated conditions such
as calciphylaxis (calcific uremic arteriolopathy), a rare but an important cause of morbidity
and mortality in patients with chronic and end-stage kidney disease [19] and vascular calcifica-
tion in uremic rats [20]. In the latter study, the prevention of calcification by STS can be
explained by the combined calcium-chelating and acidosis-inducing properties, which then
cause hypercalciuria and a negative net calcium balance. Interestingly, STS can increase the
availability of locally acting calcification inhibitors such as matrix Gla protein [20]. In addition,
STS has been reported to have antioxidant properties by acting as a free radical scavenger [21,
22]. Based on these evidences, we hypothesized that STS could decrease intra-articular cal-
cium-containing crystals deposition and OA severity. In this work, we provide new insights in
the underlying effect of STS in chondrocytes. In addition, we provide evidence that STS could
be a possible disease-modifying drug for crystal-associated OA therapy.
Materials and Methods
Mice and induction of experimental osteoarthritis
Female C57BL/6 mice (8–10 weeks old) were purchased from Charles River. All animals were
specific-pathogen-free and kept in a temperature-controlled environment in a ventilated rack
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with a 12:12-h light:dark cycle. Food and water were given ad libitum. Mice were anesthetized
via continuous isoflurane inhalation by using an automatic delivery system that provides a
mixture of isoflurane and oxygen continuously. Surgical tolerance was defined as absent pedal
withdrawal reflex response. Knee joint instability was induced surgically by partial medial
menisectomy (MNX) of the right knee, whereas the contralateral knee was sham-operated as
control [23]. After surgery, all animals were allowed to spontaneously breathe room air and
were placed under a warming light. As approved by the institutional animal care and use com-
mittee, 1.3mg/ml Paracetamol (Dafalgan, Bristol-Myers Squibb SA) was administered in drink-
ing water the first two days after surgery. Animals’ behavious was monitored every day
following menisectomy. Mice were injected i.p with 0.5 ml of STS (0.4g/Kg of body weight) or
of vehicle (PBS), three times per week and for all the duration of the experiment. 2 months
after MNX, mice were sacrificed via CO2 inhalation, knee dissected and fixed in 10% formalin.
MicroCT- scan
MicroCT-scan was performed as described before [14]. New formed calcific deposits, at the
place of the removed medial meniscus, were considered as Volumes Of Interest (VOI) for the
quantitative analysis of new formation volume (mm3) and new formation crystal content (μg).
Mouse knee histology and immunohistochemistry
After microCT-scan images acquisition, knees were decalcified in 5% formic acid, dehydrated,
and embedded in paraffin. Sagittal sections (6 μm) of the knee medial compartment (3 sec-
tions/mouse spaced 70 μM apart) were stained with Safranin-O and counterstained with fast
green/iron hematoxylin. Histological scorings (cartilage damage and Safranin-O loss) were
assessed using the OARSI score [24], by two observers blinded with regard to the mice groups.
Calcium phosphate crystals
Hydroxyapatite (HA) crystals were synthesized and characterized as previously described [25].
HA crystals were sterilized by gamma-radiation and pyrogen-free ( 0.01 EU/10 mg- by Limu-
lus amebocyte cell lysate assay). Prior to experimentation, crystals were resuspended in sterile
PBS and sonicated for 5 min.
Bone marrow derived macrophage (BMDM) preparation
Bone marrow cells were isolated from the tibia and femur of C57BL/6 mice. For their differen-
tiation into BMDM, the extracted cells were incubated for 7 days in Petri dishes with 30% L929
conditioned media (source of M-CSF) and 20% FBS in Dulbecco’s Modified Eagle Media
(DMEM). The resulting BMDM were detached using cold PBS, and plated for stimulation
experiments in either complete DMEMmedium (Gibco), (10% FBS and 1% Penicillin Strepto-
mycin (Sigma)), or incomplete DMEM (1% Penicillin Streptomycin only). For BMDM crystal
formation analysis, cells were cultivated up to 7 days in complete BJGb medium (Gibco) (10%
FBS, 50 μg/ml L-ascorbic acid 2-phosphate, 20 mM β-glycerol phosphate and 1% Penicillin
Streptomycin). Medium was changed at day 3 of culture.
Joint chondrocyte (CHs) preparation
Chondrocytes were isolated from C57BL/6 mice as described previously, with slight modifica-
tions [26]. Briefly, the joint cartilage (articular and epiphyseal) was harvested from the knee
and hip joints of mice aged between 4–6 days. The cartilage was degraded by a three step
digestion process by using decreasing concentrations of Liberase (Roche). The day after, the
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digested tissue was passed through a 70μm filter (BD biosciences) to obtain immature chon-
drocytes. The cells were plated into a culture plate at high density (3.5x104 cells/cm2) and
amplified for 7 days in complete DMEM (10% FBS, 1% Penicillin Streptomycin). Prior to
crystal stimulation experiments, cells were detached using Trypsin-EDTA (Amimed). Chon-
drocyte stimulation experiments were performedin either complete DMEMmedium (Gibco),
(10% FBS and 1% Penicillin Streptomycin (Sigma)), or incomplete DMEM (1% Penicillin
Streptomycin only). For chondrocytes crystal formation analysis, cells were cultivated as
described above for BMDM.
Calcium phosphate crystal stimulation
BMDM and chondrocytes were left overnight in cell culture plates to allow adherence to the
plate surface in complete DMEM. For experiments that required priming, cells were stimulated
overnight with TLR-ligand, Pam3Cys (100ng/ml). The next day, the media was exchanged and
the experiment was continued with incomplete DMEM or incomplete BGJb. Cells were stimu-
lated or not with sterile HA crystals at 500 μg/ml and treated or not with STS 25mM for the
indicated time. The supernatants were collected for cytokine ELISA and cells were placed in
TRIzol (Life Technologies) for Real time PCR analysis (qRT-PCR).
Crystal detection from BMDM and chondrocyte cultures
BMDM and chondrocytes were primed with Pam3Cys (100ng/ml) in complete BGJb 10% FBS,
50 μg/ml L-ascorbic acid 2-phosphate, 20 mM β-glycerol phosphate and 1% Penicillin Strepto-
mycin). The next day, medium was exchanged and cells treated or not, with STS at different
concentrations (0.2mM, 1mM, 5mM, or 25mM) in complete BGJb. After 1, 3 or 7 days, super-
natant was collected for ELISA and LDHmeasurement, and cells were washed in PBS, fixed
and crystal deposition analyzed through Alizarin red staining and quantification [27] or Von
Kossa staining as described before [28].
Real time PCR analysis
RNA was extracted (RNA Clean & Concentrator5-Zymoresearch), reverse transcribed (Super-
script II- Invitrogen™), and quantitative Real Time PCR (qRT-PCR) with gene specific primers
using the LightCycler4801system (Roche Applied Science) was performed (Table 1). Data was
normalized against Tbp and Gapdh references genes, with fold induction of transcripts calcu-
lated against the unstimulated (Nt) control cells.
Human cartilage explants experiments
Macroscopically intact knee cartilage from femoral condyles was obtained from 3 OA patients
(Kellgren-Lawrence score of 4, mean age 74±14 years) from the Orthopedics Department
(DAL, CHUV, Lausanne-CH) at time of joint replacement. Briefly, 6 mm diameter disks (9–15
disks/patient) were obtained from cartilage using a dermal punch. In order to match for loca-
tion across treatment groups, each disk was divided in two equal parts, and each half was stim-
ulated for 24h in individual 96 wells, coated with Poly(2-hydroxyethyl methacrylate) in culture
medium (DMEM + 1% Penicillin Streptomycin + 50μg/ml of L-ascorbic acid 2-phosphate).
Explants were stimulated with 500μg/ml of HA crystals in presence or absence of STS 25mM.
The following comparisons were performed: unstimulated vs HA; HA vs HA+STS; unstimu-
lated vs STS. At the end of the incubation period, supernatants were collected for IL-6 measure-
ment by ELISA and IL-6 secretion normalized by the tissue weight.
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LDHmeasurement
LDH in supernatant was measured using CytoTox-ONE™Homogeneous Membrane Integrity
Assay (Promega) according to the manufacturer’s instructions. LDH release (%) was calculated
by using the following formula. LDH release (%) = [(value in sample)—(background)] / [(value
in Triton X-100-treated sample)—(background)] x100.
Cytokine and chemokine quantification
At the reported time points of the different experiments, cell supernatants were assayed using
murine or human IL-6 and murine TNF-α, MCP-1 or IL-1β ELISA kits (eBioscience). The
manufacturer’s protocols were explicitly followed, and the results were read at 450nm using
the Spectrax M5e (Molecular devices).
ROS level measurement
Cytoplasmic ROS level was measured with dihydroethidium (DHE, Life Technologies), a
superoxide indicator which exhibits blue-fluorescence in the cytosol until oxidized and that
stains cell’s nucleus in bright fluorescent red when it intercalates within its DNA. Mitochon-
drial ROS level was measured with Red Mitochondrial Superoxide Indicator (MitoSOX, Life
Technologies), that produces red fluorescence once is oxidized by superoxide. Briefly, chondro-
cytes in half area 96-well clear bottom black plate were stimulated with HA crystals (500 μg/
ml) and treated or not with STS (25mM) for 1 hour. After stimulation, cells were loaded 30
min with DHE or MitoSOX, and fluorescence intensity was measured at 518 nm (excitation)
and 605 nm (emission) and 510 nm (excitation) and 580 nm (emission) respectively using the
Spectrax M5e (Molecular devices).
Ethics statements
Experiments in mice were performed in strict accordance to the Swiss Federal Regulations. The
protocol was approved by the “Service de la consommation et des affaires vétérinaires du Can-
ton de Vaud”, Switzerland. All efforts were made to minimize suffering
Table 1. Gene specific primers for qRT-PCR.
Gene Forward primer (5’! 3’) Reverse primer (5’! 3’)
Adamts-4 GCC CGA GTC CCA TTT CCC GC GCC ATA ACC GTC AGC AGG TAG CG
Adamts-5 GAC AGA CCT ACG ATG CCA CCC AGC ATG AGC GAG AAC ACT GAC CCC AGG
Ank TGT CAA CCT CTT CGT GTC CC GAC AAA ACA GAG CGT CAG CG
Anx5 CCT CAC GAC TCT ACG ATG CC AGC CTG GAA CAA TGC CTG AG
Coll2 ACA CTT TCC AAC CGC AGT CA GGG AGG ACG GTT GGG TAT CA
Coll10 AAA CGC CCA CAG GCA TAA AG CAA CCC TGG CTC TCC TTG G
Gapdh CTC ATG ACC ACA GTC CAT GC CAC ATT GGG GGT AGG AAC AC
Il-6 TCC AGT TGC CTT CTT GGG AC GTG TAA TTA AGC CTC CGA CT
Pc-1 CTG GTT TTG TCA GTA TGT GTG CT CTC ACC GCA CCT GAA TTT GTT
Pit-1 CTC TCC GCT GCT TTC TGG TA AGA GGT TGA TTC CGA TTG TGC
Pit-2 AAA CGC TAA TGG CTG GGG AA AAC CAG GAG GCG ACA ATC TT
Runx2 GGG AAC CAA GAA GGC ACA GA TGG AGT GGA TGG ATG GGG AT
Sox9 AAG ACT CTG GGC AAG CTC TGG A TTG TCC GTT CTT CAC CGA CTT CCT
Tbp CTT GAA ATC ATC CCT GCG AG CGC TTT CAT TAA ATT CTT GAT GGT C
Tnap TTG TGC CAG AGA AAG AGA GAG GTT TCA GGG CAT TTT TCA AGG T
doi:10.1371/journal.pone.0158196.t001
Sodium Thiosulfate Protects against Osteoarthritis
PLOS ONE | DOI:10.1371/journal.pone.0158196 July 8, 2016 5 / 16
Human samples were obtained with the approval of the Centre Hospitalier Universitaire
Vaudois ethical committee and patients written informed consent.
Statistical analysis
All values are expressed as the mean±SD. Variation between data sets was evaluated using the
Student’s t test or one-way or two-way ANOVA test, where appropriate. Differences were con-
sidered statistically significant for a value of p<0.05. Data was analysed with GraphPad Prism
software (GraphPad software), San Diego, CA.
Results
STS inhibits mineralization and reduces expression of annexin V by
murine joint chondrocytes
We first evaluated STS's effects on chondrocyte mineralization. Primary murine joint chondro-
cytes were allowed to calcify in the presence of calcifying medium and calcification was assessed at
different days: 1, 3 and 7. Calcium crystals were detected at both day 3 and day 7 by Alizarin red
and Von Kossa staining (Fig 1a, pictures). As a non-mineralizing negative control cell type, we
used murine BMDM, which in the same conditions did not produce crystals (data not shown). In
chondrocyte cultures, 25mM STS treatment resulted in a clear reduction in crystal deposits
(Fig 1a, pictures). Spectrophotometric quantification of Alizarin red staining, after crystal acidic
extraction from the entire cell monolayer, confirmed that STS inhibited by 50% chondrocyte calci-
fication at day 3 and 7 (Fig 1a, graph). This effect of STS is not due to cytotoxicity, as measured by
LDH activity (Fig 1b). The effect of STS on chondrocyte mineralization was dose-dependent from
0.2mM to 25mM as shown by decreased Alizarin-red absorbance (Fig 1c). To characterize how
STS might interfere with mineralization in chondrocyte cultures, we assessed changes in the
expression of genes involved in the calcification process (Ank, Anx5, Pit1, Pit2, Pc-1, Tnap) by
real-time PCR after 7 days in culture in the presence or the absence of 25mM STS. Results in
Fig 1d show that Anx5 expression diminished two fold in the presence of 25mM STS. In contrast,
at the same concentration, STS did not significantly alter the expression levels of the other genes.
Thus, STS inhibited calcification and the expression of Anx5 in cultured joint chondrocytes.
STS alters some aspects of chondrocyte differentiation
Chondrocyte differentiation is characterized by coordinated changes of gene expression from
early chondrocytes (expressing type 2 collagen/Coll2 and Sox9) to hypertrophic and terminally
differentiated mineralizing chondrocytes (expressing type 10 collagen/Coll10 and Runx2). We
wondered if STS reduces BCP crystal formation by blocking chondrocyte terminal differentia-
tion. To test this hypothesis, chondrocytes were cultured for 7 days in the presence or in the
absence of STS and expression levels of Coll2, Coll10, Sox9 and Runx2 were then assessed by
quantitative PCR. Results in Fig 1d show that STS induced five-fold up-regulation of Coll2 and
seven-fold up-regulation of Coll10, without altering Runx2 or Sox9 expression levels. There-
fore, STS altered expression of some chondrocyte differentiation markers in vitro, but it failed
to recapitulate the coordinated changes in expression that are typical of chondrocyte differenti-
ation (Coll2 and Sox9 down-regulation, Runx2 and Coll10 up-regulation).
STS inhibits both IL-6 production as well as downstreamMCP-1
production in chondrocytes
We recently demonstrated that BCP crystals can induce IL-6 production in chondrocytes and
that IL-6 can, in turn, promote mineralization [14]. We therefore speculated that STS, in
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addition to inhibiting crystals formation, could also affect IL-6 and IL-6-induced MCP-1 secre-
tion in chondrocytes. We found that STS inhibited ten times IL-6 secretion and two times
MCP-1 secretion, when crystals were present in chondrocyte cultures. In contrast, STS had no
effect on IL-6 secretion at day 1, when no crystals were seen in chondrocytes culture (Fig 2a).
The inhibitory effect of STS on chondrocyte IL-6 secretion was accompanied by three-fold
decreased IL-6 mRNA level, as shown by results in Fig 2b. Finally, STS's effects on IL-6 and
Fig 1. STS inhibits murine joint chondrocytesmineralization. (a) Alizarin red and Von Kossa staining of murine chondrocytes treated or not (Nt) with
25mM STS for 7 days in complete BGJb. Pictures represent one representative culture well of one experiment (five independent experiments were
performed). Scale bar 100μm. The graph shows Alizarin red absorbance at 405nm, expressed in % over Nt cells at 1, 3 or 7 days of culture. Values
represent means±SD of triplicates from one representative experiment of three independent experiments. (b) Percentage of cytotoxicity in murine
chondrocytes treated or not with 25mM STS for 1, 3 or 7 days. Values represent means±SD of triplicates from one representative experiment of three
independent experiments. (c) Alizarin red staining of murine chondrocytes treated or not (Nt) with different concentrations of STS for 7 days. Pictures
represent triplicates from one experiment. Scale bar 100μm. The graph shows Alizarin red absorbance at 405nm, expressed in % over Nt cells at 7 days
of culture. Values represent means±SD of triplicates from one representative experiment of three independent experiments. (d) qRT-PCR of the indicated
genes in murine chondrocytes treated or not with 25 mM STS for 7 days in complete DMEM. Values represent means±SD of triplicate samples. *p<0.05,
** p<0.01, *** p<0.001, **** p<0.0001. nd = not detectable
doi:10.1371/journal.pone.0158196.g001
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MCP-1 production were dose-dependent from 0.2mM to 25mM after 3 days or 7 days of cul-
ture (Fig 2c). Altogether, these results showed that both IL-6 production and downstream IL-6
mediated effects are inhibited by the presence of STS.
STS inhibits HA-induced IL-6 and MCP-1 secretion in chondrocytes and
human cartilage explants but not in BMDM
In order to investigate if STS effects are cell-specific, we stimulated both mineralizing compe-
tent cells (chondrocytes) and non-mineralizing cells (BMDM) with exogenous HA crystals in
the presence or in the absence of STS. As previously demonstrated by our group [14], HA crys-
tals significantly increased IL-6 and MCP-1 secretion in chondrocytes, after 6 hours of stimula-
tion (Fig 3a). When present for 6h or 24h at 25mM, STS was able to reduce both HA-induced
IL-6 and MCP-1 production (Fig 3a) to control levels. STS was also able to significantly dimin-
ish CPPD-induced IL-6 and MCP-1 at 24 hours (Data not shown). By contrast, STS failed to
inhibit HA-induced IL-6, IL-1β, TNF-α and MCP-1 in BMDM (Fig 3b). Finally, in both cell
types, STS had no measurable effect on the basal secretion level of the analyzed cytokines and
Fig 2. STS inhibits chondrocyte IL-6 andMCP-1 secretion in a dose-dependent manner. (a) IL-6 and MCP-1 secretion by primed murine joint
chondrocytes treated or not with 25mM STS for 1, 3 or 7 days. Values represent means±SD of triplicates from one representative experiment of three
independent experiments. (b) qRT-PCR of IL-6 gene in primed murine chondrocytes treated or not with 25 mM STS for 3 days. (c) IL-6 and MCP-1
secretion by primed murine joint chondrocytes treated or not with different concentrations of STS for 3 and 7 days. Values represent means±SD of
triplicates from one experiment. *p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
doi:10.1371/journal.pone.0158196.g002
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chemokine (Fig 3a and 3b). We have previously demonstrated, using human cartilage explants,
that HA crystals induced IL-6 secretion [14]. We speculated that STS could inhibit HA-
induced IL-6 in this setting as well. In fact, STS antagonized, although at different levels, the
effects of HA crystals on IL-6 secretion by human cartilage explants (Fig 3c).
STS inhibits HA-induced ROS generation and HA-induced matrix-
degrading enzymes in chondrocytes
As we previously reported that HA crystals induced cellular ROS [29], we asked if STS was able
to block not only cytokine and chemokine secretion but also ROS production. Indeed, in chon-
drocytes we found that STS significantly inhibited, at the control level, both mitochondrial
(detected by the MitoSOX) and cytoplasmic (detected by DHE, a fluorescent superoxide indi-
cator) ROS generated upon HA crystals stimulation (Fig 4a). In line with the selective inhibi-
tion of cytokine/chemokine in chondrocytes but not in BMDM, STS had no statistically
significant antioxidant effect in BMDM (Fig 4b). Finally, qRT-PCR analysis revealed that STS
significantly antagonized calcium-contaning crystals effect on gene expression. In particular,
STS reversed HA-induced two-fold up-regulation of genes coding for catabolic enzymes
Fig 3. STS inhibits HA-induced cytokine and chemokine selectively in chondrocytes. (a) IL-6 and MCP-1 secretion by primed murine joint
chondrocytes and (b) IL-6, MCP-1, IL-1β and TNF-α secretion by primed murine BMDM, stimulated or not with HA crystals (500ug/ml) and treated or not
with 25mM STS 25mM for 2, 6 and 24hrs. Values represent means±SD of triplicates from one representative experiment of three independent
experiments. (c) IL-6 secretion by human cartilage explants was measured by ELISA. Explants were stimulated with 500μg/ml of HA crystals in presence
or absence of STS 25Mm for 24 h. Matched-halves of cartilage explants are connected by a line (5 explants for patients 1, 3 for patient 2, 4 for patient 3).
Values represent means±SD of triplicate samples. *p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
doi:10.1371/journal.pone.0158196.g003
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(Adamts-4 and -5), and of genes involved in the calcification process (Pit2 and Tnap) (Fig 4c),
although only the inhibition of HA-induced expression of Adamts-4 and Tnap reached statisti-
cal significance.
STS inhibits formation of periarticular calcific deposits and cartilage
damage in experimental OA
As calcium crystal deposition in cartilage and around the joint is linked to human OA, we
examined if calcific deposits and cartilage degradation are linked in experimental OA. We also
investigated if the administration of STS had an effect on experimental OA. Mice were sub-
jected to knee menisectomy (MNX) and treated with STS or PBS as vehicle. Then a microCT-
scan examination was conducted 8 weeks after the beginning of treatment. Pictures on Fig 5a
show that STS administration markedly inhibited new calcific formations in knee joint. In con-
trast, bone morphometric parameters appeared similar in PBS- and STS-treated mice (results
not shown). In line with micro-CT findings, the volume of newly formed crystals, as well as the
overall newly formed crystal content, was significantly decreased in STS-treated mice by 25%
(Fig 5a, graphs). In addition, the effect of STS treatment on cartilage damage and proteoglycan
content was assessed in meniscectomized mice by Safranin-O staining, and quantified by
OARSI scoring. Pictures in Fig 5b show that PBS-treated mice are affected by cartilage fissura-
tion and fibrillation (red arrows), which were reduced by up to 40% by STS-treatment. Like-
wise, OARSI scoring revealed that STS treatment prevents cartilage damage and proteoglycan
loss although statistical significance was only reached for tibial cartilage. Interestingly, there
was a statistically significant positive correlation between the volume of the new mineralized
Fig 4. STS inhibits HA-induced ROS production and enzymes involved in cartilage degradation. ROS generation by (a) murine joint chondrocytes
and (b) BMDM stimulated or not with HA crystals (500ug/ml) and treated or not with 25mM STS for 1h. Dihydroethidium (DHE) staining was used as an
indicator of intracellular ROS generation. MitoSOX™ Red reagent was used as an indicator of mitochondrial ROS generation. Values represent means
±SD of triplicates from one representative experiment of two independent experiments and are expressed as %of ROS in unstimulated cells. (c)
qRT-PCR of the indicated genes in murine chondrocytes stimulated or not with HA crystals (500ug/ml) and treated or not with 25mM STS for 30 minutes
in DMEM. Values represent means±SD of triplicate samples. *p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
doi:10.1371/journal.pone.0158196.g004
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structures and tibial cartilage degradation score, strongly suggesting that these new deposits
have an etiologic significance in OA (Fig 5c).
Discussion
We have here provided evidence that STS significantly reduced calcium-containing crystal for-
mation both in cultured murine chondrocytes and in OA mice, thus highlighting the therapeu-
tic potential of this agent as a disease-modifying drug for crystal-associated OA. In vitro, STS
inhibited by up to 50% chondrocyte mineralization, as showed by quantification of Alizarin
red and Von Kossa staining. The inhibitory effect of STS on crystal formation was confirmed
in vivo, in menisectomy-induced OA: indeed, STS administration decreased the volume and
the crystal content of the new calcific deposits formed within the joint after MNX, and attenu-
ated tibial and femoral cartilage degradation as well as proteoglycan loss. In addition, we found
a significant positive correlation between the size of the calcific deposits and cartilage degrada-
tion score, further strengthening the notion that BCP crystals serve a pathogenic role in OA
Fig 5. STS inhibits formation of new calcific deposits and cartilage degradation in experimental OA. (a) Representative micro-CT scan images of
menisectomized murine knee joints after vehicle (PBS) or STS treatment for two months after surgery. White arrows show periarticular deposits in
menisectomized knees treated with vehicle and their reduction in STS treated mice. Graphs show CTAnalyzer quantitative analysis of new formation
volume (mm3) and new formation crystal content (μg) in PBS- and STS-treated menisectomized mice. Data are expressed as the mean±SD (b)
Representative histologies of PBS- and STS-treated menisectomized knees, stained with Safranin-O. Red arrows show degenerative OA changes in the
articular cartilage of PBS-treated mice. Scale bars 150 μm. Graphs show tibial and femoral scoring of cartilage damage and Safranin-O loss, accordingly
to OARSI method. Values represent means±SD. (c) Correlation graph between tibial cartilage damage score and new formation volume of pooled PBS-
and STS-treated mice. (Mice number: PBS n = 20, STS n = 19).
doi:10.1371/journal.pone.0158196.g005
Sodium Thiosulfate Protects against Osteoarthritis
PLOS ONE | DOI:10.1371/journal.pone.0158196 July 8, 2016 11 / 16
[13]. In keeping with its anti-mineralization effect, STS significantly reduces the expression lev-
els of Anx5, a collagen-regulated calcium channel involved in matrix vesicle-initiated cartilage
calcification [30, 31]. This result suggests that the observed STS-driven reduction in calcifica-
tion might be the consequence of reduced calcium uptake into matrix vesicles leading to inhibi-
tion of BCP crystals nucleation. In line with our hypothesis, Kirsch and colleagues [32] showed
that Anx5 overexpression promotes calcification in chondrocytes and that Anx5 down modula-
tion by the corresponding siRNA led to inhibition of mineralization [32]. Accordingly, during
pathological calcification in human OA, cartilage showed significant upregulation of Anx5 [33]
and increased release of matrix vescicles containing Anx5 [34]. By contrast, in vivo studies in
mice show normal growth plate, bone architecture and matrix vescicles distribution in Anx5-/-
and Anx5-/-Anx6-/- mice [35]. Given those discrepancies, more experiments are warranted to
substantiate our hypothesis. Regardless, our results favor this hypothesis over the notion that
STS reduces BCP crystal formation by globally altering chondrocyte differentiation status.
Indeed, whereas STS increased both Coll2 and Coll10 gene expression, it failed to modulate
Sox9 or Runx2, two markers of early and terminal chondrocytic differentiation respectively.
Thus, STS effect on mineralization cannot simply be explained in terms of a global chondrocy-
tic differentiation blockade.
In addition to its anti-mineralizing role, STS has clear anti-inflammatory effects as demon-
strated by inhibition of crystal-induced IL-6 and MCP-1 in chondrocytes. Our results are in
line with a previous report describing anti-inflammatory properties of comparable STS concen-
trations, in LPS or TNF-α-induced cytokine production by endothelial cells [36]. In agreement
with its in vitro anti-inflammatory properties, STS administration in mice improved survival
after endotoxemia [37, 38] and acute liver failure [39]. Likewise, STS attenuated both acute
lung injury [36] and ischemic brain injury [40]. Furthermore, our results demonstrated that
STS has anti-catabolic effect since it was able to inhibit HA-induced Adamts-4 and 5 up-
regulation
Previous reports have established that IL-6 production is linked to OA severity: intra-articu-
lar IL-6 injection causing OA cartilage destruction, whereas neutralization of IL-6 inhibits car-
tilage destruction in OA mouse models [41]. Likewise, in the menisectomy (MNX) model of
OA, cartilage from IL-6 knockout mice was protected from degradation when compared to
that of wild type mice [41]. Using the same MNXmodel, we found that STS treatment inhib-
ited periarticular calcification and attenuated cartilage degradation in mice. STS protective
effect on cartilage degradation could be accounted for by its inhibitory effects on chondrocyte
IL-6 secretion. Indeed, in chondrocytes, IL-6 shows both promineralizing [14] and catabolic
activity via ADAMTs up-regulation [42], and we have demonstrated that STS was able to
inhibit both effects. Whether inhibition of IL-6 expression by STS is the main mechanism
involved in cartilage protection, or whether alternative modes of action mediate STS beneficial
effects remains to be established.
Thiosulfate (S2O3
2-) is a well-known intermediate in the oxidative hydrogen sulfide (H2S)
metabolism into sulfite and sulfate. Within cells, S2O3
2- and H2S co-exist in a dynamic oxido-
reductive equilibrium that is subjected to a complex cell- and context-specific regulation [43].
Fox et al. recently showed that endogenous H2S production plays an antioxidant cytoprotective
role in mesenchymal cells cultures [44]. Although we did not monitor H2S production in
response to in vitro or in vivo STS treatment, it is likely that at least part of the antioxidant
effect of exogenous STS reported herein is linked to increased H2S signaling. We indeed dem-
onstrated that STS inhibits HA-induced ROS production by chondrocytes. Further studies are
needed to investigate whether the underlying mechanism of this effect is due to STS modula-
tion of ROS generating enzymes or of antioxidant enzymes. Interestingly, published studies
demonstrated that ROS are in turn implied in calcification. They modulate initiation of the
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hypertrophic changes in chondrocytes [45] and they induce calcification of human dental pulp
cells [46]. Agharazii et al. showed a relationship between ROS and arterial calcification in
chronic kidney disease patients [47]. We will therefore investigate whether ROS are able to
induce calcification in our chondrocyte cultures and if STS is able to block this effect. In vivo,
STS might therefore be active both upstream and downstream to IL-6R signaling by modulat-
ing IL-6 production and preventing resulting oxydative stress respectively [48]. In this context,
the apparent cell selectivity of STS treatment (inhibitory in chondrocytes but not in macro-
phages), could relate to lineage specific differences in ROS production, S2O3
2- transport and/or
H2S homeostasis.
Of note, the doses of STS used in our study, both in vitro (25mM) and in vivo (0.4g/Kg)
were very similar to those reported before in in vitro [36], preclinical [20] [36] and clinical
studies [49–51], where efficacy was reached with low cytotoxicity and side effects. In our exper-
iments we have used STS in a preventive way, at time of OA induction. Future experiments will
be performed to verify that STS can act not only in preventive, but also in a curative approach.
In conclusion, our results reveal a novel beneficial role of STS in osteoarthritis, which may lead
to the development of new therapeutics aimed at preventing or reducing intra-articular calcifi-
cations and disease progression.
Acknowledgments
We thank Nathaliane Bagnoud and Véronique Chobaz for their excellent technical support.
We are grateful to Dr Laurent Galibert for his suggestions, critical reading and editing of the
manuscript. Hydroxyapatite (HA) and calcium pyrophosphate dihydrate (CPPD) crystals were
kindly provided by Prof. Christèle Combes (CIRIMAT, INPT-UPS-CNRS, Toulouse France).
This work was supported by the Fonds national suisse de la recherche scientifique (grant
310030-130085/1).
Author Contributions
Conceived and designed the experiments: SN NB. Performed the experiments: SN NB. Ana-
lyzed the data: SN NB. Contributed reagents/materials/analysis tools: SN AS NB. Wrote the
paper: SN HKE FL AS NB.
References
1. Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage dis-
eases. Best practice & research Clinical rheumatology 2006; 20:1003–25.
2. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ.
Arthritis and rheumatism 2012; 64:1697–707. doi: 10.1002/art.34453 PMID: 22392533
3. Nalbant S, Martinez JA, Kitumnuaypong T, Clayburne G, Sieck M, Schumacher HR Jr. Synovial fluid
features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthri-
tis and cartilage / OARS, Osteoarthritis Research Society 2003; 11:50–4. PMID: 12505487
4. Fuerst M, Bertrand J, Lammers L, Dreier R, Echtermeyer F, Nitschke Y, et al. Calcification of articular
cartilage in human osteoarthritis. Arthritis and rheumatism 2009; 60:2694–703. doi: 10.1002/art.24774
PMID: 19714647
5. McCarthy GM, Augustine JA, Baldwin AS, Christopherson PA, Cheung HS, Westfall PR, et al. Molecu-
lar mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of
nuclear factor kappab, activator protein 1, and protein kinase c. The Journal of biological chemistry
1998; 273:35161–9. PMID: 9857053
6. Nair D, Misra RP, Sallis JD, Cheung HS. Phosphocitrate inhibits a basic calcium phosphate and cal-
cium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal trans-
duction pathway. The Journal of biological chemistry 1997; 272:18920–5. PMID: 9228071
Sodium Thiosulfate Protects against Osteoarthritis
PLOS ONE | DOI:10.1371/journal.pone.0158196 July 8, 2016 13 / 16
7. Brogley MA, Cruz M, Cheung HS. Basic calcium phosphate crystal induction of collagenase 1 and stro-
melysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction
pathway. Journal of cellular physiology 1999; 180:215–24. PMID: 10395291
8. Sun Y, Wenger L, Brinckerhoff CE, Misra RR, Cheung HS. Basic calcium phosphate crystals induce
matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metallopro-
teinase 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3. The Journal of
biological chemistry 2002; 277:1544–52. PMID: 11682465
9. Reuben PM, Sun Y, Cheung HS. Basic calcium phosphate crystals activate p44/42 MAPK signal trans-
duction pathway via protein kinase Cmicro in human fibroblasts. The Journal of biological chemistry
2004; 279:35719–25. PMID: 15190081
10. Ea HK, Uzan B, Rey C, Liote F. Octacalcium phosphate crystals directly stimulate expression of induc-
ible nitric oxide synthase through p38 and JNKmitogen-activated protein kinases in articular chondro-
cytes. Arthritis Res Ther 2005; 7:R915–26. PMID: 16207333
11. Nadra I, Mason JC, Philippidis P, Florey O, Smythe CD, McCarthy GM, et al. Proinflammatory activation
of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a
vicious cycle of inflammation and arterial calcification? Circulation research 2005; 96:1248–56. PMID:
15905460
12. CunninghamCC, Mills E, Mielke LA, O'Farrell LK, Lavelle E, Mori A, et al. Osteoarthritis-associated
basic calcium phosphate crystals induce pro-inflammatory cytokines and damage-associated mole-
cules via activation of Syk and PI3 kinase. Clinical immunology 2012; 144:228–36. doi: 10.1016/j.clim.
2012.06.007 PMID: 22854286
13. Ea HK, Chobaz V, Nguyen C, Nasi S, van Lent P, Daudon M, et al. Pathogenic role of basic calcium
phosphate crystals in destructive arthropathies. PLoS One 2013; 8:e57352. doi: 10.1371/journal.pone.
0057352 PMID: 23468973
14. Nasi S, So A, Combes C, Daudon M, Busso N. Interleukin-6 and chondrocyte mineralisation act in tan-
dem to promote experimental osteoarthritis. Annals of the rheumatic diseases 2015.
15. Cheung HS, Sallis JD, Demadis KD, Wierzbicki A. Phosphocitrate blocks calcification-induced articular
joint degeneration in a guinea pig model. Arthritis and rheumatism 2006; 54:2452–61. PMID: 16869019
16. Sun Y, Mauerhan DR, Franklin AM, Norton J, Hanley EN Jr., Gruber HE. Phosphocitrate is potentially a
disease-modifying drug for noncrystal-associated osteoarthritis. BioMed research international 2013;
2013:326267. doi: 10.1155/2013/326267 PMID: 23555081
17. Ramjan KA, Roscioli T, Rutsch F, Sillence D, Munns CF. Generalized arterial calcification of infancy:
treatment with bisphosphonates. Nature clinical practice Endocrinology & metabolism 2009; 5:167–72.
18. Ding M, Danielsen CC, Hvid I. The effects of bone remodeling inhibition by alendronate on three-dimen-
sional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Calcified tis-
sue international 2008; 82:77–86. doi: 10.1007/s00223-007-9093-2 PMID: 18175032
19. Hayden MR, Goldsmith DJ. Sodium thiosulfate: new hope for the treatment of calciphylaxis. Semin Dial
2010; 23:258–62. doi: 10.1111/j.1525-139X.2010.00738.x PMID: 20636917
20. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S. Sodium thiosulfate prevents vascular
calcifications in uremic rats. Kidney international 2008; 74:1444–53. doi: 10.1038/ki.2008.455 PMID:
18818688
21. Karageuzyan KG. Oxidative stress in the molecular mechanism of pathogenesis at different diseased
states of organism in clinics and experiment. Current drug targets Inflammation and allergy 2005; 4:85–
98. PMID: 15720241
22. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R. Vascular ossification-calcification in metabolic
syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolo-
pathy: the emerging role of sodium thiosulfate. Cardiovascular diabetology 2005; 4:4. PMID: 15777477
23. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development
in novel experimental mouse models induced by knee joint instability. Osteoarthritis and cartilage /
OARS, Osteoarthritis Research Society 2005; 13:632–41. PMID: 15896985
24. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage
histopathology: grading and staging. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Soci-
ety 2006; 14:13–29. PMID: 16242352
25. Prudhommeaux F, Schiltz C, Liote F, Hina A, Champy R, Bucki B, et al. Variation in the inflammatory
properties of basic calcium phosphate crystals according to crystal type. Arthritis and rheumatism
1996; 39:1319–26. PMID: 8702440
26. Gosset M, Berenbaum F, Thirion S, Jacques C. Primary culture and phenotyping of murine chondro-
cytes. Nat Protoc 2008; 3:1253–60. doi: 10.1038/nprot.2008.95 PMID: 18714293
Sodium Thiosulfate Protects against Osteoarthritis
PLOS ONE | DOI:10.1371/journal.pone.0158196 July 8, 2016 14 / 16
27. Gregory CA, GunnWG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adher-
ent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004; 329:77–
84. PMID: 15136169
28. Horn DA, Garrett IR. A novel method for embedding neonatal murine calvaria in methyl methacrylate
suitable for visualizing mineralization, cellular and structural detail. Biotechnic & histochemistry: official
publication of the Biological Stain Commission 2004; 79:151–8.
29. Ives A, Nomura J, Martinon F, Roger T, LeRoy D, Miner JN, et al. Xanthine oxidoreductase regulates
macrophage IL1beta secretion upon NLRP3 inflammasome activation. Nature communications 2015;
6:6555. doi: 10.1038/ncomms7555 PMID: 25800347
30. von der Mark K, Mollenhauer J. Annexin V interactions with collagen. Cellular and molecular life sci-
ences: CMLS 1997; 53:539–45. PMID: 9230933
31. Kim HJ, Kirsch T. Collagen/annexin V interactions regulate chondrocyte mineralization. The Journal of
biological chemistry 2008; 283:10310–7. doi: 10.1074/jbc.M708456200 PMID: 18281278
32. WangW, Xu J, Kirsch T. Annexin V and terminal differentiation of growth plate chondrocytes. Experi-
mental cell research 2005; 305:156–65. PMID: 15777796
33. Mollenhauer J, Mok MT, King KB, Gupta M, Chubinskaya S, Koepp H, et al. Expression of anchorin CII
(cartilage annexin V) in human young, normal adult, and osteoarthritic cartilage. The journal of histo-
chemistry and cytochemistry: official journal of the Histochemistry Society 1999; 47:209–20.
34. Kirsch T, Swoboda B, Nah H. Activation of annexin II and V expression, terminal differentiation, mineral-
ization and apoptosis in human osteoarthritic cartilage. Osteoarthritis and cartilage / OARS, Osteoar-
thritis Research Society 2000; 8:294–302. PMID: 10903884
35. Grskovic I, Kutsch A, Frie C, Groma G, Stermann J, Schlotzer-Schrehardt U, et al. Depletion of annexin
A5, annexin A6, and collagen X causes no gross changes in matrix vesicle-mediated mineralization,
but lack of collagen X affects hematopoiesis and the Th1/Th2 response. Journal of bone and mineral
research: the official journal of the American Society for Bone and Mineral Research 2012; 27:2399–
412.
36. Sakaguchi M, Marutani E, Shin HS, ChenW, Hanaoka K, Xian M, et al. Sodium thiosulfate attenuates
acute lung injury in mice. Anesthesiology 2014; 121:1248–57. doi: 10.1097/ALN.0000000000000456
PMID: 25260144
37. Tokuda K, Kida K, Marutani E, Crimi E, Bougaki M, Khatri A, et al. Inhaled hydrogen sulfide prevents
endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice.
Antioxidants & redox signaling 2012; 17:11–21.
38. Abdoon AS, Kandil OM, Zeng SM, Cui M. Mitochondrial distribution, ATP-GSH contents, calcium [Ca2
+] oscillation during in vitro maturation of dromedary camel oocytes. Theriogenology 2011; 76:1207–
14. doi: 10.1016/j.theriogenology.2011.05.019 PMID: 21820723
39. Shirozu K, Tokuda K, Marutani E, Lefer D, Wang R, Ichinose F. Cystathionine gamma-lyase deficiency
protects mice from galactosamine/lipopolysaccharide-induced acute liver failure. Antioxidants & redox
signaling 2014; 20:204–16.
40. Marutani E, Yamada M, Ida T, Tokuda K, Ikeda K, Kai S, et al. Thiosulfate Mediates Cytoprotective
Effects of Hydrogen Sulfide Against Neuronal Ischemia. Journal of the American Heart Association
2015; 4.
41. Ryu JH, Yang S, Shin Y, Rhee J, Chun CH, Chun JS. Interleukin-6 plays an essential role in hypoxia-
inducible factor 2alpha-induced experimental osteoarthritic cartilage destruction in mice. Arthritis and
rheumatism 2011; 63:2732–43. doi: 10.1002/art.30451 PMID: 21590680
42. Legendre F, Bogdanowicz P, Boumediene K, Pujol JP. Role of interleukin 6 (IL-6)/IL-6R-induced signal
tranducers and activators of transcription and mitogen-activated protein kinase/extracellular. The Jour-
nal of rheumatology 2005; 32:1307–16. PMID: 15996070
43. Ju Y, ZhangW, Pei Y, Yang G. H(2)S signaling in redox regulation of cellular functions. Canadian jour-
nal of physiology and pharmacology 2013; 91:8–14. doi: 10.1139/cjpp-2012-0293 PMID: 23368534
44. Fox B, Schantz JT, Haigh R, Wood ME, Moore PK, Viner N, et al. Inducible hydrogen sulfide synthesis
in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the
inflamed joint? Journal of cellular and molecular medicine 2012; 16:896–910. doi: 10.1111/j.1582-
4934.2011.01357.x PMID: 21679296
45. Morita K, Miyamoto T, Fujita N, Kubota Y, Ito K, Takubo K, et al. Reactive oxygen species induce chon-
drocyte hypertrophy in endochondral ossification. The Journal of experimental medicine 2007;
204:1613–23. PMID: 17576777
46. Matsui S, Takahashi C, Tsujimoto Y, Matsushima K. Stimulatory effects of low-concentration reactive
oxygen species on calcification ability of human dental pulp cells. Journal of endodontics 2009; 35:67–
72. doi: 10.1016/j.joen.2008.08.034 PMID: 19084128
Sodium Thiosulfate Protects against Osteoarthritis
PLOS ONE | DOI:10.1371/journal.pone.0158196 July 8, 2016 15 / 16
47. Agharazii M, St-Louis R, Gautier-Bastien A, Ung RV, Mokas S, Lariviere R, et al. Inflammatory cyto-
kines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcifica-
tion. American journal of hypertension 2015; 28:746–55. doi: 10.1093/ajh/hpu225 PMID: 25430697
48. Mathy-Hartert M, Hogge L, Sanchez C, Deby-Dupont G, Crielaard JM, Henrotin Y. Interleukin-1beta
and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation
for oxidative stress generation. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society
2008; 16:756–63. doi: 10.1016/j.joca.2007.10.009 PMID: 18291685
49. Neuwelt EA, Brummett RE, Doolittle ND, Muldoon LL, Kroll RA, Pagel MA, et al. First evidence of oto-
protection against carboplatin-induced hearing loss with a two-compartment system in patients with
central nervous systemmalignancy using sodium thiosulfate. The Journal of pharmacology and experi-
mental therapeutics 1998; 286:77–84. PMID: 9655844
50. MarkmanM, Cleary S, Pfeifle CE, Howell SB. High-dose intracavitary cisplatin with intravenous thiosul-
fate. Low incidence of serious neurotoxicity. Cancer 1985; 56:2364–8. PMID: 2994877
51. Goel R, Cleary SM, Horton C, Kirmani S, Abramson I, Kelly C, et al. Effect of sodium thiosulfate on the
pharmacokinetics and toxicity of cisplatin. Journal of the National Cancer Institute 1989; 81:1552–60.
PMID: 2552131
Sodium Thiosulfate Protects against Osteoarthritis
PLOS ONE | DOI:10.1371/journal.pone.0158196 July 8, 2016 16 / 16
